Poniard Pharmaceuticals, Inc.

PARD · OTC
Analyze with AI
9/30/2011
6/30/2011
3/31/2011
12/31/2010
Operating Activities
Net Income$0$0-$3-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$2
Change in WC$1$1-$0-$3
Other Non-Cash-$4-$4$0$1
Operating Cash Flow-$2-$2-$2-$5
Investing Activities
PP&E Inv.$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$3$9
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0$3$9
Financing Activities
Debt Repay.$0$0$0-$14
Stock Issued$0$0$3$0
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0-$0
Financing Cash Flow$0-$0$3-$14
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$2$4-$10
Supplemental Information
Beg. Cash$4$5$1$11
End Cash$2$4$5$1
Free Cash Flow-$2-$2-$2-$5